Hoth Therapeutics, Inc.
HOTH
$1.20
$0.065.26%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 32.07% | 8.89% | 7.67% | 17.91% | -12.97% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 50.41% | 29.66% | 23.89% | 6.83% | -14.28% |
| Operating Income | -50.41% | -29.66% | -23.89% | -6.83% | 14.28% |
| Income Before Tax | -51.13% | -30.12% | -21.43% | -4.47% | 16.35% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -51.13% | -30.12% | -21.43% | -4.47% | 16.35% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -51.13% | -30.12% | -21.43% | -4.47% | 16.35% |
| EBIT | -50.41% | -29.66% | -23.89% | -6.83% | 14.28% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 29.56% | 39.04% | 44.38% | 44.49% | 68.04% |
| Normalized Basic EPS | 29.45% | 38.88% | 42.89% | 43.08% | 65.01% |
| EPS Diluted | 29.56% | 39.04% | 44.38% | 44.49% | 68.04% |
| Normalized Diluted EPS | 29.45% | 38.88% | 42.89% | 43.08% | 65.01% |
| Average Basic Shares Outstanding | 108.59% | 109.90% | 117.61% | 87.08% | 113.28% |
| Average Diluted Shares Outstanding | 108.59% | 109.90% | 117.61% | 87.08% | 113.28% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |